In Vitro Activity of ABT 773, a New Ketolide Antibiotic, against Chlamydia pneumoniae

AUTOR(ES)

Strigl, Sebastian

FONTE

American Society for Microbiology

RESUMO

The in vitro activities of ABT 773, telithromycin (HMR 3647), azithromycin, clarithromycin, erythromycin, and levofloxacin were tested against 20 strains of Chlamydia pneumoniae. The MIC at which 90% of the isolates were inhibited and the minimal bactericidal concentration at which 90% of the isolates were killed by ABT 773 were 0.015 μg/ml (range, 0.008 to 0.015 μg/ml). ABT 773 was the most active antibiotic tested in this study.

Documentos Relacionados

• In Vitro Activity of a New Ketolide Antibiotic, HMR 3647, against Chlamydia pneumoniae
• In Vitro Activity of ABT-773, a New Ketolide, against Recent Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
• In Vitro Activity of the Ketolide ABT-773
• In Vitro Activity of a New Antibiotic, NVP-PDF386 (VRC4887), against Chlamydia pneumoniae
• In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.